Hematologic Oncology Update

By: Dr. Neil Love
  • Summary

  • Featuring one-on-one interviews conducted by Dr Neil Love, this series provides medical oncologists with access to an array of important perspectives and information on relevant advances in the treatment of hematologic cancer to facilitate optimal patient care.
    Copyright 2025 Research To Practice. All Rights Reserved
    Show more Show less
Episodes
  • Relapsed/Refractory Follicular Lymphoma Part 1 — A Roundtable Discussion on the Selection and Sequencing of Therapy
    Apr 22 2025

    Dr Carla Casulo from Wilmot Cancer Institute in Rochester, New York, Dr Matthew Matasar from Rutgers Cancer Institute of New Jersey in New Brunswick and Dr Laurie H Sehn from BC Cancer Centre for Lymphoid Cancer in Vancouver discuss recent updates on available and novel treatment strategies for relapsed/refractory follicular lymphoma.

    CME information and select publications here.

    Show more Show less
    40 mins
  • Oncology Nursing Update Special 2-Part Edition: Bispecific Antibodies in Lymphoma — Part 2
    Apr 18 2025

    Nurse practitioner Ms Amy Goodrich from The Sidney Kimmel Comprehensive Care Center in Baltimore, Maryland, presents cases from her practice illustrating the efficacy and safety of bispecific antibodies for non-Hodkin lymphoma.

    NCPD information and select publications here.

    Show more Show less
    58 mins
  • Myelofibrosis — An Interview with Dr Raajit K Rampal on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting
    Apr 15 2025

    Dr Raajit K Rampal from Memorial Sloan Kettering Cancer Center in New York, New York, discusses recent updates on available and novel treatment strategies for myelofibrosis.

    CME information and select publications here.

    Show more Show less
    43 mins
adbl_web_global_use_to_activate_webcro768_stickypopup

What listeners say about Hematologic Oncology Update

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.